Advanced search
Publication Cover
Expert Review of Vaccines Volume 5, 2006 - Issue 4
Submit an article Journal homepage
80
Views
25
CrossRef citations to date
0
Altmetric
Review

Antigen-specific T-cell-mediated immunity after HIV-1 infection: implications for vaccine control of HIV development

Michael R Betts University of Pennsylvania, Department of Microbiology, 522E Johnson Pavilion, 3610 Hamilton Walk, Philadelphia, PA 19104, USA. [email protected]
,
Clive M Gray National Institute for Communicable Diseases, AIDS Unit, Private Bag X4, Sandringham 2131, Johannesburg, South Africa. [email protected]
,
Josephine H Cox Walter Reed Army Institute of Research, Chief Cellular Immunology Section, Division of Retrovirology, US Military HIV Research Program, Suite 200, 13 Taft Court Rockville, MD 20850, USA. [email protected]
&
Guido Ferrari Duke University Medical Center, Department of Experimental Surgery, P.O. Box 2926 Durham, NC 27710, USA. [email protected]
Pages 505-516 | Published online: 09 Jan 2014

References

  • Brander C, Walker BD. Modulation of host immune responses by clinically relevant human DNA and RNA viruses. Curr. Opin. Microbiol.3(4), 379–386 (2000).
  • Barouch DH, Letvin NL. CD8+ cytotoxic T lymphocyte responses to lentiviruses and herpesviruses. Curr. Opin. Immunol.13(4), 479–482 (2001).
  • Walker CM, Moody DJ, Stites DP, Levy JA. CD8+ lymphocytes can control HIV infection in vitro suppressing virus replication. Science234, 1563–1566 (1986).
  • Walker BD, Chakrabarti S, Moss B et al. HIV-specific cytotoxic T lymphocytes in seropositive individuals. Nature328, 345–348 (1987).
  • Nixon D, Townsend A, Elvin J, Rizza C, Gallwey J, McMichael A. HIV-1 gag-specific cytotoxic T lymphocytes defined with recombinant vaccinia virus and synthetic peptides. Nature336, 484–487 (1988).
  • Borrow P, Lewicki H, Hahn BH, Shaw GM, Oldstone MB. A virus-specific CD8+ cytotoxic T lymphocyte activity associated with control viremia in primary human immunodeficiency virus type 1 infection. J. Virol..68, 6103–6110 (1994).
  • Koup RA, Safrit JF, Cao Y et al. Temporal association of cellular immune response with the initial control of viremia in primary human immunodeficiency virus type 1 syndrome. J. Virol.68(7), 4650–4655 (1994).
  • Safrit JT, Andrews CA, Zhu T, Ho DD, Koup RA. Characterization of human immunodeficiency virus type 1-specific cytotoxic T lymphocyte clones isolated during acute seroconversion: recognition of autologous virus sequences within a conserved immunodominant epitope. J. Exp. Med.179(2), 463–472 (1994).
  • Rinaldo C, Huang X-L, Fan Z et al. High levels of anti-human immunodeficiency virus type 1 (HIV-1) memory cytotoxic T-lymphocyte activity and low viral load are associated with lack of disease in HIV-1-infected long-term nonprogressors. J. Virol.69(9), 5838–5842 (1995).
  • Riviere Y, McChesney MB, Porrot F et al. Gag-specific cytotoxic responses to HIV type 1 are associated with a decreased risk of progression to AIDS-related complex or AIDS. AIDS Res. Hum. Retroviruses11(8), 903–907 (1995).
  • Greenough TC, Brettler DB, Somasundaran M, Panicali DL, Sullivan JL. Human immunodeficiency virus type-1-specific cytotoxic T lymphocytes (CTL), virus load, and CD4 T cell loss: evidence supporting a protective role for CTL in vivo.J. Inf. Dis.176, 118–125 (1997).
  • Harrer T, Harrer E, Kalamas SA et al. Strong cytotoxic T cell and weak neutralizing antibody responses in a subset of persons with stable nonprogressing HIV type 1 infection. AIDS Res. Hum. Retroviruses12(7), 585–592 (1996).
  • Cheynier R, Langlade-Demoyen P, Marescot M-R et al. Cytotoxic T lymphocyte responses in the peripheral Blood of children born to HIV-1 infected mother. Eur. J. Immunol.22, 2211–2217 (1992).
  • Rowland-Jones SL, Nixon DF, Aldhous MC et al. HIV-specific cytotoxic T-cell activity in an HIV-exposed but uninfected infant. Lancet341(8849), 860–861 (1993).
  • Rowland-Jones S, Sutton J, Ariyoshi K et al. HIV-specific citotoxic T-cells in HIV-exposed but uninfected Gambian women. Nature Med.1(1), 59–64 (1995).
  • Henkart PA. Lymphocyte-mediated cytotoxicity: two pathways and multiple effector molecules. Immunity1(5), 343–346 (1994).
  • Henkart PA. Mechanism of lymphocyte-mediated cytotoxicity. Ann. Rev. Immunol.3, 31–58 (1985).
  • Bossi G, Griffiths GM. Degranulation plays an essential part in regulating cell surface expression of Fas ligand in T cells and natural killer cells. Nat. Med.5(1), 90–96 (1999).
  • Wagner L, Yang OO, Garcia-Zepeda EA et al. β-chemokines are released from HIV-1-specific cytolytic T-cell granules complexed to proteoglycans. Nature391(6670), 908–911 (1998).
  • Catalfamo M, Karpova T, McNally J et al. Human CD8+ T cells store RANTES in a unique secretory compartment and release it rapidly after TcR stimulation. Immunity20(2), 219–230 (2004).
  • Appay V, Zaunders JJ, Papagno L et al. Characterization of CD4(+) CTLs ex vivo.J. Immunol.168(11), 5954–5958 (2002).
  • Papagno L, Appay V, Sutton J et al. Comparison between HIV- and CMV-specific T cell responses in long-term HIV infected donors. Clin. Exp. Immunol.130(3), 509–517 (2002).
  • Norris PJ, Moffett HF, Yang OO et al. Beyond help: direct effector functions of human immunodeficiency virus type 1-specific CD4+ T cells. J. Virol.78(16), 8844–8851 (2004).
  • Picker LJ, Singh MK, Zdraveski Z et al. Direct demonstration of cytokine synthesis heterogeneity among human memory/effector T cells by flow cytometry. Blood86(4), 1408–1419 (1995).
  • Bevan MJ. Helping the CD8(+) T-cell response. Nat. Rev. Immunol.4(8), 595–602 (2004).
  • Shedlock DJ, Shen H. Requirement for CD4 T cell help in generating functional CD8 T cell memory. Science300(5617), 337–339 (2003).
  • Sun JC, Bevan MJ. Defective CD8 T cell memory following acute infection without CD4 T cell help. Science300(5617), 339–342 (2003).
  • Becker TC, Wherry EJ, Boone D et al. Interleukin 15 is required for proliferative renewal of virus-specific memory CD8 T cells. J. Exp. Med.195(12), 1541–1548 (2002).
  • Tan JT, Ernst B, Kieper WC, LeRoy E, Sprent J, Surh CD. Interleukin (IL)-15 and IL-7 jointly regulate homeostatic proliferation of memory phenotype CD8+ cells but are not required for memory phenotype CD4+ cells. J. Exp. Med.195(12), 1523–1532 (2002).
  • Janssen EM, Lemmens EE, Wolfe T, Christen U, von Herrath MG, Schoenberger SP. CD4+ T cells are required for secondary expansion and memory in CD8+ T lymphocytes. Nature421(6925), 852–856 (2003).
  • Haseltine WA. Molecular biology of the human immunodeficiency virus type 1. Faseb J.5(10), 2349–2360 (1991).
  • Gruters RA, van Baalen CA, Osterhaus AD. The advantage of early recognition of HIV-infected cells by cytotoxic T-lymphocytes. Vaccine20(15), 2011–2015 (2002).
  • van Baalen CA, Guillon C, van Baalen M et al. Impact of antigen expression kinetics on the effectiveness of HIV-specific cytotoxic T lymphocytes. Eur. J. Immunol.32(9), 2644–2652 (2002).
  • Ali A, Lubong R, Ng H, Brooks DG, Zack JA, Yang OO. Impacts of epitope expression kinetics and class I downregulation on the antiviral activity of human immunodeficiency virus type 1-specific cytotoxic T lymphocytes. J. Virol.78(2), 561–567 (2004).
  • Addo MM, Altfeld M, Rosenberg ES et al. The HIV-1 regulatory proteins Tat and Rev are frequently targeted by cytotoxic T lymphocytes derived from HIV-1-infected individuals. Proc. Natl Acad. Sci. USA98(4), 1781–1786 (2001).
  • Altfeld M, Addo MM, Eldridge RL et al. Vpr is preferentially targeted by CTL during HIV-1 infection. J. Immunol.167(5), 2743–2752 (2001).
  • Masemola A, Mashishi T, Khoury G et al. Hierarchical targeting of subtype C HIV-1 proteins by CD8+ T cells: correlation with viral load. J. Virol.78(7), 3233–3243 (2004).
  • McMichael AJ, Phillips RE. Escape of human immunodeficiency virus from immune control. Ann. Rev. Immunol.15, 271–296 (1997).
  • Goulder PJ, Watkins DI. HIV and SIV CTL escape: implications for vaccine design. Nat. Rev. Immunol.4(8), 630–640 (2004).
  • Geretti AM. HIV-1 subtypes: epidemiology and significance for HIV management. Curr. Opin. Infect. Dis.19(1), 1–7 (2006).
  • Pantaleo G, Demarest JF, Schacker T et al. The qualitative nature of the primary immune response to HIV infection is a prognosticator of disease progression independent of the initial level of plasma viremia. Proc. Natl Acad. Sci. USA94(1), 254–258 (1997).
  • Alexander-Miller MA, Leggatt GR, Berzofsky JA. Selective expansion of high- or low-avidity cytotoxic T lymphocytes and efficacy for adoptive immunotherapy. Proc. Natl Acad. Sci. USA93(4), 4102–4107 (1996).
  • Alexander-Miller MA, Leggatt GR, Sarin A, Berzofsky JA. Role of antigen, CD8, and cytotoxic T lymphocyte (CTL) avidity in high dose antigen induction of apoptosis of effector CTL. J. Exp. Med.184(2), 485–492 (1996).
  • Yee C, Savage PA, Lee PP, Davis MM, Greenberg PD. Isolation of high avidity melanoma-reactive CTL from heterogeneous populations using peptide-MHC tetramers. J. Immunol.162(4), 2227–2234 (1999).
  • Pantaleo G, Soudeyns H, Demarest JF et al. Evidence for rapid disappearance of initially expanded HIV-specific CD8+ T cell clones during primary HIV infection. Proc. Natl Acad. Sci. USA94(18), 9848–9853 (1997).
  • Snyder JT, Alexander-Miller MA, Berzofskyl JA, Belyakov IM. Molecular mechanisms and biological significance of CTL avidity. Curr. HIV Res.1(3), 287–294 (2003).
  • Lichterfeld M, Yu XG, Cohen D et al. HIV-1 Nef is preferentially recognized by CD8 T cells in primary HIV-1 infection despite a relatively high degree of genetic diversity. AIDS18(10), 1383–1392 (2004).
  • Pantaleo G, Fauci AS. New concepts in the immunopathogenesis of HIV infection. Ann. Rev. Immunol.13, 487–512 (1995).
  • Borrow P, Lewicki H, Wei X et al. Antiviral pressure exerted by HIV-1-specific cytotoxic T lymphocytes (CTLs) during primary infection demonstrated by rapid selection of CTL escape virus. Nat. Med.3(2), 205–217 (1997).
  • Price DA, Goulder PJ, Klenerman P et al. Positive selection of HIV-1 cytotoxic T lymphocyte escape variants during primary infection. Proc. Natl Acad. Sci. USA94, 1890–1895 (1997).
  • O’Connor DH, Allen TM, Vogel TU et al. Acute phase cytotoxic T lymphocyte escape is a hallmark of simian immunodeficiency virus infection. Nat. Med.493–499 (2002).
  • Yusim K, Kesmir C, Gaschen B et al. Clustering patterns of cytotoxic T-lymphocyte epitopes in human immunodeficiency virus type 1 (HIV-1) proteins reveal imprints of immune evasion on HIV-1 global variation. J. Virol.76(17), 8757–8768 (2002).
  • Ogg GS, Jin X, Bonhoeffer S et al. Quantitation of HIV-1-specific cytotoxic T lymphocytes and plasma load of viral RNA. Science279(5359), 2103–2106 (1998).
  • Dalod M, Dupuis M, Deschemin JC et al. Weak anti-HIV CD8(+) T-cell effector activity in HIV primary infection. J. Clin. Invest.104(10), 1431–1439 (1999).
  • Gea-Banacloche JC, Migueles SA, Martino L et al. Maintenance of large numbers of virus-specific CD8+ T cells in HIV-infected progressors and long-term nonprogressors. J Immunol.165(2), 1082–1092 (2000).
  • Betts MR, Ambrozak DR, Douek DC et al. Analysis of total human immunodeficiency virus (HIV)-specific CD4(+) and CD8(+) T-cell responses: relationship to viral load in untreated HIV infection. J. Virol.75(24), 11983–11991 (2001).
  • Edwards BH, Bansal A, Sabbaj S, Bakari J, Mulligan MJ, Goepfert PA. Magnitude of functional CD8+ T-cell responses to the gag protein of human immunodeficiency virus type 1 correlates inversely with viral load in plasma. J. Virol.76(5), 2298–2305 (2002).
  • Addo MM, Yu XG, Rathod A et al. Comprehensive epitope analysis of human immunodeficiency virus type 1 (HIV-1)-specific T-cell responses directed against the entire expressed HIV-1 genome demonstrate broadly directed responses, but no correlation to viral load. J. Virol.77(3), 2081–2092 (2003).
  • Migueles SA, Laborico AC, Shupert WL et al. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors. Nat. Immunol.3(11), 1061–1068 (2002).
  • Zimmerli SC, Harari A, Cellerai C, Vallelian F, Bart PA, Pantaleo G. HIV-1-specific IFN-γ/IL-2-secreting CD8 T cells support CD4-independent proliferation of HIV-1-specific CD8 T cells. Proc. Natl Acad. Sci. USA102(20), 7239–7244 (2005).
  • Betts M, Nason MC, West SM et al. HIV nonprogressors preferentially maintain highly functional HIV-specific CD8+ T-cells. Blood107(12), 4781–4789 (2006).
  • Appay V, Nixon DF, Donahoe SM et al. HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function. J. Exp. Med.192(1), 63–76 (2000).
  • Lieberman J, Shankar P, Manjunath N, Andersson J. Dressed to kill? A review of why antiviral CD8 T lymphocytes fail to prevent progressive immunodeficiency in HIV-1 infection. Blood98(6), 1667–1677 (2001).
  • McCutchan FE, Sankale JL, M’Boup S et al. HIV type 1 circulating recombinant form CRF09_cpx from west Africa combines subtypes A, F, G, and may share ancestors with CRF02_AG and Z321. AIDS Res. Hum. Retroviruses20(8), 819–826 (2004).
  • Cao H, Kanki P, Sankale’ J-L et al. Cytotoxic T-lymphocyte cross-reactivity among different human immunodeficiency virus type 1 clades: implications for vaccine development. J. Virol.71(11), 8615–8623 (1997).
  • Betts MR, Krowka J, Santamaria C et al. Cross-clade human immunodeficiency virus (HIV)-specific cytotoxic T-lymphocyte responses in HIV-infected Zambians. J. Virol.71(11), 8908–8911 (1997).
  • Lynch JA, DeSouza M, Robb MD et al. Cross-clade cytotoxic T cell response to HIV-1 proteins among HLA disparate North Americans and Thais. J. Infect. Dis.178(4), 1040–1046 (1998).
  • Wilson SE, Pedersen SL, Kunich JC et al. Cross-clade envelope glycoprotein 160-specific CD8+ cytotoxic T lymphocyte responses in early HIV type 1 clade B infection. AIDS Res. Hum. Retroviruses14(11), 925–937 (1998).
  • Dorrell L, Dong T, Ogg GS et al. Distinct recognition of non-clade B human immunodeficiency virus type 1 epitopes by cytotoxic T lymphocytes generated from donors infected in Africa. J. Virol.73(2), 1708–1714 (1999).
  • Buseyne F, Chaix ML, Fleury B et al. Cross-clade-specific cytotoxic T lymphocytes in HIV-1-infected children. Virology250(2), 316–324 (1998).
  • Gillespie GM, Kaul R, Dong T et al. Cross-reactive cytotoxic T lymphocytes against a HIV-1 p24 epitope in slow progressors with B*57. AIDS16(7), 961–972 (2002).
  • Coplan PM, Gupta SB, Dubey SA et al. Cross-reactivity of anti-HIV-1 T cell immune responses among the major HIV-1 clades in HIV-1-positive individuals from 4 continents. J. Infect. Dis.191(9), 1427–1434 (2005).
  • McKinnon LR, Ball TB, Kimani J et al. Cross-clade CD8(+) T-cell responses with a preference for the predominant circulating clade. J. Acquir. Immune Defic. Syndr.40(3), 245–249 (2005).
  • Barugahare B, Baker C, K'Aluoch O et al. Human immunodeficiency virus-specific responses in adult Ugandans: patterns of cross-clade recognition. J. Virol.79(7), 4132–4139 (2005).
  • Ferrari G, Humphrey W, McElrath MJ et al. Clade B-based HIV-1 vaccines elicit cross-clade cytotoxic T lymphocyte reactivities in uninfected volunteers. Proc. Natl Acad. Sci. USA94, 1396–1401 (1997).
  • Ferrari G, Neal W, Jones A et al. CD8 CTL responses in vaccinees: emerging patterns of HLA restricition and epitope recognition. Immunology Letters79(1–2), 37–45 (2001).
  • Novitsky V, Rybak N, McLane MF et al. Identification of human immunodeficiency virus type 1 subtype C Gag-, Tat-, Rev-, and Nef-specific elispot-based cytotoxic T-lymphocyte responses for AIDS vaccine design. J. Virol.75(19), 9210–9228 (2001).
  • Rutebemberwa A, Currier JR, Jagodzinski L et al. HIV-1 MN Env 15-mer peptides better detect HIV-1 specific CD8 T cell responses compared with consensus subtypes B and M group 15-mer peptides. AIDS19(11), 1165–1172 (2005).
  • Altfeld M, Allen TM, Yu XG et al. HIV-1 superinfection despite broad CD8+ T-cell responses containing replication of the primary virus. Nature420(6914), 434–439 (2002).
  • Yang OO, Daar ES, Jamieson BD et al. Human immunodeficiency virus type 1 clade B superinfection: evidence for differential immune containment of distinct clade B strains. J. Virol.79(2), 860–868 (2005).
  • Hoelscher M, Dowling WE, Sanders-Buell E et al. Detection of HIV-1 subtypes, recombinants, and dual infections in east Africa by a multi-region hybridization assay. AIDS16(15), 2055–2064 (2002).
  • Masemola AM, Mashishi TN, Khoury G et al. Novel and promiscuous CTL epitopes in conserved regions of Gag targeted by individuals with early subtype C HIV type 1 infection from Southern Africa. J. Immunol.173(7), 4607–4617 (2004).
  • Geels MJ, Dubey SA, Anderson K et al. Broad cross-clade T-cell responses to gag in individuals infected with human immunodeficiency virus type 1 non-B clades (A to G): importance of HLA anchor residue conservation. J. Virol.79(17), 11247–11258 (2005).
  • Gaschen B, Taylor J, Yusim K et al. Diversity considerations in HIV-1 vaccine selection. Science296(5577), 2354–2360 (2002).
  • Rosenberg ES, Billingsley JM, Caliendo AM et al. Vigorous HIV-1specific CD4+ T cell responses associated with control of viremia. Science278, 1447–1450 (1997).
  • Lichterfeld M, Kaufmann DE, Yu XG et al. Loss of HIV-1-specific CD8+ T cell proliferation after acute HIV-1 infection and restoration by vaccine-induced HIV-1-specific CD4+ T cells. J. Exp. Med.200(6), 701–712 (2004).
  • Brenchley JM, Schacker TW, Ruff LE et al. CD4+ T cell depletion during all stages of HIV disease occurs predominantly in the gastrointestinal tract. J. Exp. Med.200(6), 749–759 (2004).
  • Veazey RS, DeMaria M, Chalifoux LV et al. Gastrointestinal tract as a major site of CD4+ T cell depletion and viral replication in SIV infection. Science280(5362), 427–431 (1998).
  • Douek DC, Brenchley JM, Betts MR et al. HIV preferentially infects HIV-specific CD4+ T cells. Nature417(6884), 95–98 (2002).
  • Legac E, Autran B, Merle-Beral H, Katlama C, Debre P. CD4+CD7-CD57+ T cells: a new T-lymphocyte subset expanded during human immunodeficiency virus infection. Blood79(7), 1746–1753 (1992).
  • Harari A, Rizzardi GP, Ellefsen K et al. Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection. Blood100(4), 1381–1387 (2002).
  • Brenchley JM, Hill BJ, Ambrozak DR et al. T-cell subsets that harbor human immunodeficiency virus (HIV) in vivo: implications for HIV pathogenesis. J. Virol.78(3), 1160–1168 (2004).
  • Palmer BE, Blyveis N, Fontenot AP, Wilson CC. Functional and phenotypic characterization of CD57+CD4+ T cells and their association with HIV-1-induced T cell dysfunction. J. Immunol.175(12), 8415–8423 (2005).
  • Harrer T, Harrer E, Kalams SA et al. Cytotoxic T lymphocytes in asymptomatic long-term nonprogressing HIV-1 infection. J. Immunol.156, 2616–2623 (1996).
  • Migueles SA, Sabbaghian MS, Shupert WL et al. HLA B*5701 is highly associated with restriction of virus replication in a subgroup of HIV-infected long term nonprogressors. Proc. Natl Acad. Sci. USA97(6), 2709–2714 (2000).
  • O'Brien SJ, Gao X, Carrington M. HLA and AIDS: a cautionary tale. Trends Mol. Med.7(9), 379–381 (2001).
  • Leslie AJ, Pfafferott KJ, Chetty P et al. HIV evolution: CTL escape mutation and reversion after transmission. Nat. Med.10(3), 282–289 (2004).
  • Goulder PJ, Brander C, Tang Y et al. Evolution and transmission of stable CTL escape mutations in HIV infection. Nature412(6844), 334–338 (2001).
  • Gao X, Bashirova A, Iversen AK et al. AIDS restriction HLA allotypes target distinct intervals of HIV-1 pathogenesis. Nat. Med.11(12), 1290–1292 (2005).
  • Goulder PJ, Phillips RE, Colbert RA et al. Late escape from an immunodominant cytotoxic T-lymphocyte response associated with progression to AIDS. Nat. Med.3(2), 212–217 (1997).
  • Kelleher AD, Long C, Holmes EC et al. Clustered mutations in HIV-1 gag are consistently required for escape from HLA-B27-restricted cytotoxic T lymphocyte responses. J. Exp. Med.193(3), 375–386 (2001).
  • Feeney ME, Tang Y, Roosevelt KA et al. Immune escape precedes breakthrough human immunodeficiency virus type 1 viremia and broadening of the cytotoxic T-lymphocyte response in an HLA-B27-positive long-term-nonprogressing child. J. Virol.78(16), 8927–8930 (2004).
  • Currier JR, Harris ME, Cox JH et al. Immunodominance and cross-reactivity of B5703-restricted CD8 T lymphocytes from HIV type 1 subtype C-infected Ethiopians. AIDS Res. Hum. Retroviruses21(3), 239–245 (2005).
  • Martin MP, Gao X, Lee JH et al. Epistatic interaction between KIR3DS1 and HLA-B delays the progression to AIDS. Nat. Gen.31(4), 429–434 (2002).
  • Deacon NJ, Tsykin A, Solomon A et al. Genomic structure of an attenuated quasi species of HIV-1 from a blood transfusion donor and recipients. Science270(5238), 988–991 (1995).
  • Thornton AM, Shevach EM. Suppressor effector function of CD4+CD25+ immunoregulatory T cells is antigen nonspecific. J. Immunol.164(1), 183–190 (2000).
  • Orendi JM, Bloem AC, Borleffs JC et al. Activation and cell cycle antigens in CD4+ and CD8+ T cells correlate with plasma human immunodeficiency virus (HIV-1) RNA level in HIV-1 infection. J. Infect. Dis.178(5), 1279–1287 (1998).
  • Sousa AE, Carneiro J, Meier-Schellersheim M, Grossman Z, Victorino RM. CD4 T cell depletion is linked directly to immune activation in the pathogenesis of HIV-1 and HIV-2 but only indirectly to the viral load. J. Immunol.169(6), 3400–3406 (2002).
  • Hazenberg MD, Otto SA, van Benthem BH et al. Persistent immune activation in HIV-1 infection is associated with progression to AIDS. AIDS17(13), 1881–1888 (2003).
  • Hazenberg MD, Hamann D, Schuitemaker H, Miedema F. T cell depletion in HIV-1 infection: how CD4+ T cells go out of stock. Nat. Immunol.1(4), 285–289 (2000).
  • Douek DC. Disrupting T-cell homeostasis: how HIV-1 infection causes disease. AIDS Rev.5(3), 172–177 (2003).
  • Ho HN, Hultin LE, Mitsuyasu RT et al. Circulating HIV-specific CD8+ cytotoxic T cells express CD38 and HLA-DR antigens. J Immunol.150(7), 3070–3079 (1993).
  • Giorgi JV, Lyles RH, Matud JL et al. Predictive value of immunologic and virologic markers after long or short duration of HIV-1 infection. J. AIDS29(4), 346–355 (2002).
  • Eggena MP, Barugahare B, Jones N et al. Depletion of regulatory T cells in HIV infection is associated with immune activation. J. Immunol.174(7), 4407–4414 (2005).
  • Kinter AL, Hennessey M, Bell A et al. CD25(+)CD4(+) regulatory T cells from the peripheral blood of asymptomatic HIV-infected individuals regulate CD4(+) and CD8(+) HIV-specific T cell immune responses in vitro and are associated with favorable clinical markers of disease status. J. Exp. Med.200(3), 331–343 (2004).
  • Weiss L, Donkova-Petrini V, Caccavelli L, Balbo M, Carbonneil C, Levy Y. Human immunodeficiency virus-driven expansion of CD4+CD25+ regulatory T cells which suppress HIV-specific CD4 T-cell responses in HIV-infected patients. Blood104(10), 3249–3256 (2004).
  • Boritz E, Palmer BE, Wilson CC. Human immunodeficiency virus type 1 (HIV-1)-specific CD4+ T cells that proliferate in vitro detected in samples from most viremic subjects and inversely associated with plasma HIV-1 levels. J. Virol.78(22), 12638–12646 (2004).
  • Garba ML, Pilcher CD, Bingham AL, Eron J, Frelinger JA. HIV antigens can induce TGF-β(1)-producing immunoregulatory CD8+ T cells. J. Immunol.168(5), 2247–2254 (2002).
  • Toka FN, Suvas S, Rouse BT. CD4+ CD25+ T cells regulate vaccine-generated primary and memory CD8+ T-cell responses against herpes simplex virus type 1. J. Virol.78(23), 13082–13089 (2004).
  • Klein MR, van Baalen CA, Holwerda AM et al. Kinetics of Gag-specific cytotoxic T lymphocyte responses during the clinical course of HIV-1 infection: a longitudinal analysis of rapid progressors and long-term asymptomatics. J. Exp. Med.181, 1365–1372 (1995).
  • Betts MR, Krowka JF, Kepler TB et al. Human immunodeficiency virus type 1-specific cytotoxic T lymphocyte activity is inversely correlated with HIV type 1 viral load in HIV type 1-infected long-term survivors. AIDS Res. Hum. Retroviruses15(13), 1219–28 (1999).
  • Altman JD, Moss PA, Goulder PJ et al. Phenotypic analysis of antigen-specific T lymphocytes. Science274(5284), 94–96 (1996).
  • De Rosa SC, Herzenberg LA, Roederer M. 11-color, 13-parameter flow cytometry: identification of human naive T cells by phenotype, function, and T-cell receptor diversity. Nat. Med.7(2), 245–248 (2001).
  • Roederer M, Brenchley JM, Betts MR, De Rosa SC. Flow cytometric analysis of vaccine responses: how many colors are enough? Clin. Immunol.110(3), 199–205 (2004).
  • Sheehy ME, McDermott AB, Furlan SN, Klenerman P, Nixon DF. A novel technique for the fluorometric assessment of T lymphocyte antigen specific lysis. J. Immunol. Methods249(1–2), 99–110 (2001).
  • Herbeck JT, Nickle DC, Learn GH et al. Human immunodeficiency virus type 1 env evolves toward ancestral states upon transmission to a New Host. J. Virol.80(4), 1637–44 (2006).
  • Wilson NA, Reed J, Napoe GS et al. Vaccine-induced cellular immune responses reduce plasma viral concentrations after repeated low-dose challenge with pathogenic simian immunodeficiency virus SIVmac239. J. Virol.80(12), 5875–5885 (2006).
  • Mattapallil JJ, Douek DC, Buckler-White A et al. Vaccination preserves CD4 memory T cells during acute simian immunodeficiency virus challenge. J. Exp. Med.203(6), 1533–1541 (2006).
  • Letvin NL, Mascola JR, Sun Y et al. Preserved CD4+ central memory T cells and survival in vaccinated SIV-challenged monkeys. Science312(5779), 1530–1533 (2006).

Website

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.